MedTrace Logo

The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease

NCT04021888 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-07-17

No results posted yet for this study

Summary

The primary aim of this trial is to investigate the feasibility of an exercise program consisting of respiratory exercises, aerobic exercises and strengthening exercises in mild to moderate Alzheimer's disease. The trial also aims to investigate the effectiveness of the exercise program on respiratory symptoms, exercise capacity, cognition, physical performance, depression, sleepiness, activities of daily living and quality of life.

Patients will be divided into exercise (intervention) and control group by randomization method. The study is planned to be performed with a total of 60 patients, 30 in each group. The patients in the exercise group will be given breathing exercises aerobic exercises and strengthening exercises for 2 days a week for 12 weeks, about 30-40 minutes while the patients in the control group will be provided with suggestions, home exercise program and daily life activities

Conditions

  • Alzheimer Disease
  • Aerobic Exercise
  • Breathing Exercise
  • Resistance Training

Interventions

OTHER

Exercise

Education of patients and their caregivers, deep breathing exercise, aerobic exercise and resistance training with elastic bands

Sponsors & Collaborators

  • Sevgi Ozalevli

    collaborator UNKNOWN

  • Gorsev Yener

    collaborator UNKNOWN

  • Dokuz Eylul University

    lead OTHER

Principal Investigators

  • Elvan Keleş, PT, PhD · İzmir Katip Çelebi Üniversitesi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-16
Primary Completion
2018-10-08
Completion
2020-07-30

Countries

  • Turkey (Türkiye)

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021888 on ClinicalTrials.gov